CRBP icon

Corbus Pharmaceuticals

140 hedge funds and large institutions have $383M invested in Corbus Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 42 funds opening new positions, 46 increasing their positions, 27 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
140
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$49.2M
Puts
$24.8M
Net Calls
Net Calls Change

Top Buyers

1 +$25.5M
2 +$15.9M
3 +$12.6M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$6.94M
5
Morgan Stanley
Morgan Stanley
New York
+$4.79M
Name Holding Trade Value Shares
Change
Change in
Stake
51
$685K
52
$631K
53
$579K
54
$553K
55
$532K
56
$530K
57
$521K
58
$487K
59
$481K
60
$480K
61
$479K
62
$437K
63
$425K
64
$409K
65
$387K
66
$375K
67
$373K
68
$340K
69
$327K
70
$307K
71
$305K
72
$298K
73
$280K
74
$273K
75
$271K